Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Precision Optics Corporation, Inc. (POCI)
USD4.77
-0.03 (-0.63%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
22 East Broadway 1440
Gardner, MA, US
Gardner, MA, US
CEO
Joseph N. Forkey
Website
poci.com
IPO
1992-01-16
CIK 867840 ISIN US7402944000
Also trades on
NASDAQ Capital Market · POCI (USD)
Other OTC · PEYE (USD)
Description
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.77
-0.03 (-0.63%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
49.9K
Beta
0.31
Float Shares
5.73M
Free Float %
74.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.11% | -4.22% | +2.48% | -4.62% | -6.00% | +8.61% | -0.87% | -30.15% | -10.98% | +196.73% | -99.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
4.77
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-2.02
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-0.1% Q1'26: +108.0% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-73.5% Q1'26: +96.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-27.6% Q1'26: -7.7% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-29.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-44.3% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+11.9% Q1'26: +12.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.38× Q1'26: -13.28× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2023 actual |
Jun 2024 actual |
|---|---|---|
| Revenue |
21.04M
est: 21.04M (+0.0%)
|
19.10M
est: 42.09M (-54.6%)
|
| EBITDA |
287.0K
est: -1.53M (+118.8%)
|
-2.51M
est: -3.06M (+17.8%)
|
| EBIT |
76.3K
est: -1.75M (+104.4%)
|
-2.72M
est: -3.50M (+22.2%)
|
| Net Income |
-144.6K
|
-2.95M
|
| SGA |
7.38M
est: 7.40M (-0.3%)
|
7.54M
est: 14.80M (-49.1%)
|
| EPS |
-0.03
|
-0.49
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.91M
OE per share TTM
-0.42
Owner's Yield
-8.32%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
4.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
3
Total invested
632.2K
Insider transactions (90d)
0
Beneficial owners (>5%)
6
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | George A. Needham | 322.5K | 5.31% | — | 322.5K | — | 322.5K | HC, IN | Delaware | 2024-05-17 | ↗ |
| 2 | Needham Aggressive Growth Fund | 322.5K | 5.31% | — | 322.5K | — | 322.5K | IV, OO | Delaware | 2024-05-17 | ↗ |
| 3 | Needham Asset Management, LLC | 322.5K | 5.31% | — | 322.5K | — | 322.5K | HC, OO | Delaware | 2024-05-17 | ↗ |
| 4 | Needham Investment Management L.L.C. | 322.5K | 5.31% | — | 322.5K | — | 322.5K | IA, OO | Delaware | 2024-05-17 | ↗ |
| 5 | Peter V. Anania | 232.4K | 4.10% | 223.5K | 9.0K | 223.5K | 9.0K | IN | — | 2023-04-17 | ↗ |
| 6 | Anania & Associates Investment Company, LLC | — | 0.00% | — | — | — | — | OO | — | 2023-04-17 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
3
-16 vs prev Q
New positions
1
Closed positions
17
Increased
1
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NEEDHAM INVESTMENT MANAGEMENT LLC | 720.0K +20.0K (+2.9%) | 3.01M -31.8K (-1.0%) | 9.33% -0.976 pp | 0.19% -0.022 pp | USD5.09 -17.9% | 13 qtrs — |
| 2 | WEALTHTRUST AXIOM LLC | 231.8K +6.2K (+2.7%) | 970.1K -11.5K (-1.2%) | 3.00% -0.318 pp | 0.25% -0.013 pp | USD6.16 -32.1% | 12 qtrs — |
| 3 | VANGUARD GROUP INC | 223.5K +1.6K (+0.7%) | 935.2K -29.9K (-3.1%) | 2.90% -0.371 pp | 0.00% +0.000 pp | USD5.10 -18.0% | 10 qtrs — |
| 4 | BLEICHROEDER LP | 220.2K +— (+0.0%) | 921.7K -36.3K (-3.8%) | 2.85% -0.389 pp | 0.16% -0.025 pp | USD4.77 -12.4% | 6 qtrs — |
| 5 | HIGHTOWER ADVISORS, LLC | 96.6K +— (+0.0%) | 404.1K -15.9K (-3.8%) | 1.25% -0.170 pp | 0.00% +0.000 pp | USD5.20 -19.6% | 13 qtrs — |
| 6 | MORGAN STANLEY | 92.0K +14.0K (+18.0%) | 385.0K +45.7K (+13.5%) | 1.19% +0.044 pp | 0.00% +0.000 pp | USD5.13 -18.5% | 13 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 58.4K +1.9K (+3.4%) | 244.6K -1.3K (-0.5%) | 0.76% -0.075 pp | 0.00% +0.000 pp | USD5.63 -25.8% | 9 qtrs — |
| 8 | DRW SECURITIES, LLC | 22.5K +22.5K (+100.0%) | 94.3K +94.3K (+100.0%) | 0.29% +0.292 pp | 0.00% +0.003 pp | USD4.18 +0.0% | 1 qtrs NEW |
| 9 | CITADEL ADVISORS LLC | 22.1K +10.9K (+97.0%) | 92.3K +43.6K (+89.5%) | 0.29% +0.121 pp | 0.00% +0.000 pp | USD4.27 -2.1% | 2 qtrs — |
| 10 | NORTHERN TRUST CORP | 16.6K +16.6K (+100.0%) | 69.5K +69.5K (+100.0%) | 0.22% +0.215 pp | 0.00% +0.000 pp | USD4.18 +0.0% | 1 qtrs NEW |
| 11 | BLACKROCK, INC. | 14.8K -1.9K (-11.2%) | 62.0K -10.6K (-14.6%) | 0.19% -0.054 pp | 0.00% +0.000 pp | USD5.28 -20.8% | 6 qtrs — |
| 12 | JANE STREET GROUP, LLC | 11.6K +11.6K (+100.0%) | 48.5K +48.5K (+100.0%) | 0.15% +0.150 pp | 0.00% +0.000 pp | USD4.18 +0.0% | 1 qtrs NEW |
| 13 | TOWER RESEARCH CAPITAL LLC (TRC) | 837.00 +381.0 (+83.6%) | 3.5K +1.5K (+76.6%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD4.73 -11.6% | 12 qtrs — |
| 14 | UBS GROUP AG | 716.00 -41.5K (-98.3%) | 3.0K -180.6K (-98.4%) | 0.01% -0.612 pp | 0.00% +0.000 pp | USD4.84 -13.6% | 7 qtrs — |
| 15 | FRONT ROW ADVISORS LLC | 26.00 +— (+0.0%) | 109.00 -4.0 (-3.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.92 -29.4% | 10 qtrs — |
| 16 | BANQUE TRANSATLANTIQUE SA | 10.00 +— (+0.0%) | 42.00 -1.0 (-2.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.80 -12.9% | 5 qtrs — |
| 17 | BANK OF AMERICA CORP /DE/ | 5.00 +— (+0.0%) | 21.00 -1.0 (-4.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.60 -25.4% | 9 qtrs — |
| 18 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 5.00 +— (+0.0%) | 21.00 -1.0 (-4.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.40 -22.6% | 13 qtrs — |
| 19 | FINANCIAL PERSPECTIVES, INC | 2.00 +— (+0.0%) | 8.00 -1.0 (-11.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.50 -24.0% | 13 qtrs — |
| 20 | MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | — -23.4K (-100.0%) | — -101.6K (-100.0%) | 0.00% -0.344 pp | 0.00% -0.002 pp | USD— | 9 qtrs SOLD |
| 21 | JUNIPER INVESTMENT COMPANY, LLC | — -15.5K (-100.0%) | — -67.4K (-100.0%) | 0.00% -0.228 pp | 0.00% -0.026 pp | USD— | 7 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 126.9K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 375.5K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 2.9K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 7.9K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 586.41 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.36M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 3.0K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.6K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 653.90 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 72.05 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.50
Bullish
Ratio by volume
3.00
Bullish
Buys
5
Sells
2
Shares acquired
85.5K
Shares disposed
26.4K
Cash buys
3.00
Cash sales
—
Net activity
+59,083
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,568 | 3.99 | 6.2K | 36,807 | D | ↗ |
| 2026-03-30 | TRAUT JOSEPH | Officer | P-Purchase | A | Common Stock | 41,666 | 3.60 | 150.0K | 41,666 | D | ↗ |
| 2026-03-30 | Forkey Joseph Norman | Director / Officer | P-Purchase | A | Common Stock | 1,388 | 3.60 | 5.0K | 143,959 | D | ↗ |
| 2026-03-30 | COLL WAYNE M | Officer | P-Purchase | A | Common Stock | 20,833 | 3.60 | 75.0K | 35,239 | D | ↗ |
| 2026-03-27 | NEEDHAM INVESTMENT MANAGEMENT LLC | 10% Owner | — | — | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 1,670,550 | I | ↗ |
| 2026-03-12 | Miclot Andrew J. | Director | M-Exempt | A | Common Stock | 20,000 | 1.44 | 28.8K | 20,000 | D | ↗ |
| 2025-12-31 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,420 | 6,250.00 | 8.88M | 14,406 | D | ↗ |
| 2025-11-17 | Woodward Peter H | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 4.33 | 129.9K | 30,000 | D | ↗ |
| 2025-11-17 | Pellegrino Joseph P JR | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 4.33 | 129.9K | 30,000 | D | ↗ |
| 2025-11-17 | Miclot Andrew J. | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 4.33 | 129.9K | 30,000 | D | ↗ |
| 2025-11-17 | Duncan Buell | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 4.33 | 129.9K | 30,000 | D | ↗ |
| 2025-10-01 | TRAUT JOSEPH | Officer | A-Award | A | Stock Options (Rights to buy) | 60,000 | 4.34 | 260.4K | 60,000 | D | ↗ |
| 2025-09-30 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,370 | 6,250.00 | 8.56M | 12,986 | D | ↗ |
| 2025-06-30 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,405 | 6,250.00 | 8.78M | 11,616 | D | ↗ |
| 2025-05-16 | Woodward Peter H | Director | M-Exempt | A | Common Stock | 30,000 | 2.19 | 65.7K | 30,000 | D | ↗ |
| 2025-03-31 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,333 | 6,250.00 | 8.33M | 10,211 | D | ↗ |
| 2025-03-19 | Pellegrino Joseph P JR | Director | A-Award | A | Stock Options (Rights to buy) | 15,000 | 4.71 | 70.7K | 15,000 | D | ↗ |
| 2025-03-19 | Miclot Andrew J. | Director | A-Award | A | Stock Options (Rights to buy) | 5,000 | 4.71 | 23.6K | 5,000 | D | ↗ |
| 2025-03-19 | Lawande Mahesh | Officer | A-Award | A | Stock Options (Rights to buy) | 40,000 | 4.71 | 188.4K | 40,000 | D | ↗ |
| 2025-03-19 | Forkey Joseph Norman | Director / Officer | A-Award | A | Stock Options (Rights to buy) | 80,000 | 4.71 | 376.8K | 80,000 | D | ↗ |
| 2025-03-19 | Duncan Buell | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 4.71 | 141.3K | 30,000 | D | ↗ |
| 2025-03-19 | COLL WAYNE M | Officer | A-Award | A | Stock Options (Rights to buy) | 50,000 | 4.71 | 235.5K | 50,000 | D | ↗ |
| 2025-02-28 | Duncan Buell | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-21 | Woodward Peter H | Director | A-Award | A | Common Stock | 102,500 | 4.00 | 410.0K | 327,171 | I | ↗ |
| 2024-12-31 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,331 | 5,769.24 | 7.68M | 8,878 | D | ↗ |
| 2024-11-20 | Anania Peter V. | Director | S-Sale | D | Common Stock | 14,400 | 5.00 | 72.0K | 196,198 | D | ↗ |
| 2024-11-18 | Woodward Peter H | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 5.00 | 150.0K | 30,000 | D | ↗ |
| 2024-11-18 | Miles Richard B | Director | A-Award | A | Stock Options (Rights to buy) | 20,000 | 5.00 | 100.0K | 20,000 | D | ↗ |
| 2024-11-18 | Miclot Andrew J. | Director | A-Award | A | Stock Options (Rights to buy) | 20,000 | 5.00 | 100.0K | 20,000 | D | ↗ |
| 2024-11-18 | Anania Peter V. | Director | A-Award | A | Stock Options (Rights to buy) | 20,000 | 5.00 | 100.0K | 20,000 | D | ↗ |
| 2024-09-30 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,110 | 6,730.78 | 7.47M | 7,547 | D | ↗ |
| 2024-08-15 | Lawande Mahesh | Officer | P-Purchase | A | Common Stock | 1,726 | 9,993.54 | 17.25M | 1,726 | — | ↗ |
| 2024-08-15 | Forkey Joseph Norman | Director / Officer | P-Purchase | A | Common Stock | 1,725 | 9,987.75 | 17.23M | 122,572 | — | ↗ |
| 2024-08-15 | COLL WAYNE M | Officer | P-Purchase | A | Common Stock | 4,317 | 24,995.43 | 107.91M | 4,317 | — | ↗ |
| 2024-06-30 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,039 | 5,769.24 | 5.99M | 6,437 | D | ↗ |
| 2024-03-31 | COLL WAYNE M | Officer | A-Award | A | Common Stock | 1,081 | 6,730.78 | 7.28M | 5,398 | D | ↗ |
| 2023-12-30 | Miles Richard B | Director | M-Exempt | D | Director Option (Right to Buy) | 1,000 | 2.70 | 2.7K | 0 | D | ↗ |
| 2023-11-16 | Woodward Peter H | Director | A-Award | A | Stock Options (Rights to buy) | 45,000 | 5.95 | 267.8K | 135,000 | — | ↗ |
| 2023-11-16 | Miles Richard B | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 5.95 | 178.5K | 90,998 | — | ↗ |
| 2023-11-16 | Miclot Andrew J. | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 5.95 | 178.5K | 89,998 | — | ↗ |
| 2023-11-16 | Anania Peter V. | Director | A-Award | A | Stock Options (Rights to buy) | 30,000 | 5.95 | 178.5K | 56,666 | — | ↗ |
| 2023-06-16 | Anania Peter V. | Director | J-Other | A | Common Stock | 4,827 | 0.00 | — | 201,648 | — | ↗ |
| 2023-06-12 | COLL WAYNE M | Officer | — | D | Stock Option (Right to Buy) | 50,000 | 6.94 | 347.0K | 0 | — | ↗ |
| 2023-04-24 | Lawande Mahesh | Officer | — | D | Stock Option (Right to Buy) | 60,000 | 6.40 | 384.0K | 0 | — | ↗ |
| 2023-01-26 | Forkey Joseph Norman | Officer | W-Will | A | Common Stock | 4,974 | 0.00 | — | 120,847 | — | ↗ |
| 2023-01-16 | Woodward Peter H | Director | A-Award | A | Stock Options (Rights to buy) | 20,000 | 0.00 | — | 90,000 | — | ↗ |
| 2023-01-16 | Miles Richard B | Director | A-Award | A | Stock Options (Rights to buy) | 13,334 | 0.00 | — | 62,133 | — | ↗ |
| 2023-01-16 | Miclot Andrew J. | Director | A-Award | A | Stock Options (Rights to buy) | 13,334 | 0.00 | — | 60,000 | — | ↗ |
| 2023-01-16 | Anania Peter V. | Director | A-Award | A | Stock Options (Rights to buy) | 13,334 | 0.00 | — | 26,666 | — | ↗ |
| 2023-01-05 | Dahill Edward Kevin | Officer | — | D | Stock Option (Right to Buy) | 4,000 | 5.93 | 23.7K | — | — | ↗ |
| 2022-11-30 | Anania Peter V. | Director | P-Purchase | A | Common Stock | 332 | 6.00 | 2.0K | 8,950 | — | ↗ |
| 2022-11-16 | Woodward Peter H | Director | A-Award | A | Stock Options (Rights to buy) | 10,000 | 0.00 | — | 70,000 | — | ↗ |
| 2022-11-16 | Miles Richard B | Director | A-Award | A | Stock Options (Rights to buy) | 6,666 | 0.00 | — | 48,799 | — | ↗ |
| 2022-11-16 | Miclot Andrew J. | Director | A-Award | D | Stock Options (Rights to buy) | 6,666 | 0.00 | — | 46,666 | — | ↗ |
| 2022-11-16 | Anania Peter V. | Director | A-Award | A | Stock Options (Rights to buy) | 6,666 | 0.00 | — | 13,332 | — | ↗ |
| 2022-11-01 | Habhegger Daniel S | Officer | A-Award | A | Stock Option (Right to Buy) | 16,667 | 0.00 | — | 76,667 | — | ↗ |
| 2022-11-01 | Forkey Joseph Norman | Officer | A-Award | A | Stock Option (Right to Buy) | 16,667 | 0.00 | — | 183,333 | — | ↗ |
| 2022-09-16 | Anania Peter V. | Director | J-Other | D | Common Stock | 232,915 | 0.00 | — | 0 | — | ↗ |
| 2022-09-07 | Anania Peter V. | Director | J-Other | A | Common Stock | 8,618 | 0.00 | — | 8,618 | — | ↗ |
| 2022-05-31 | Anania Peter V. | Director | J-Other | A | Common Stock | 232,915 | 0.00 | — | 232,915 | — | ↗ |
| 2007-11-27 | Miles Richard B | Director | A-Award | A | Stock Option (to buy) | 10,000 | 0.31 | 3.1K | 30,000 | — | ↗ |
| 2007-02-01 | MARXE AUSTIN W & GREENHOUSE DAVID M | 10% Owner | P-Purchase | A | Warrants | 8,000,000 | 0.32 | 2.56M | 8,000,000 | — | ↗ |
| 2006-11-28 | Miles Richard B | Director | A-Award | A | Stock Option (to buy) | 10,000 | 0.25 | 2.5K | 20,000 | — | ↗ |
| 2006-04-13 | Miles Richard B | Director | P-Purchase | A | Common Stock | 100,000 | 0.25 | 25.0K | 100,000 | — | ↗ |
| 2005-12-31 | MARXE AUSTIN W & GREENHOUSE DAVID M | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,777,358 | — | ↗ |
| 2005-11-29 | Miles Richard B | Director | A-Award | A | Stock Option (to buy) | 10,000 | 0.46 | 4.6K | 10,000 | — | ↗ |
| 2005-06-27 | SHANNON ROBERT R | Director | A-Award | A | Stock Option (to buy) | 10,000 | 0.73 | 7.3K | 0 | — | ↗ |
| 2005-06-13 | FORKEY RICHARD E | Director / Officer | A-Award | A | Stock Option (to buy) | 373,600 | 0.83 | 310.1K | 373,600 | — | ↗ |
| 2004-11-29 | SHANNON ROBERT R | Director | A-Award | A | Stock Option (to buy) | 5,000 | 0.87 | 4.4K | 16,671 | — | ↗ |
| 2004-07-19 | SHANNON ROBERT R | Director | J-Other | A | Common Stock | 2,502 | 1.00 | 2.5K | 3,336 | — | ↗ |
| 2004-07-19 | FORKEY RICHARD E | Director / Officer | J-Other | A | Common Stock | 20,000 | 1.00 | 20.0K | 315,378 | — | ↗ |
| 2004-07-19 | DREIMILLER JACK P | Officer | J-Other | A | Common Stock | 20,390 | 1.00 | 20.4K | 24,557 | — | ↗ |
| 2003-11-11 | SHANNON ROBERT R | Director | A-Award | A | Stock Option (to buy) | 834 | 1.95 | 1.6K | 11,671 | — | ↗ |
| 2003-11-11 | MARXE AUSTIN W | Director | A-Award | A | Stock Option (to buy) | 834 | 1.95 | 1.6K | 5,004 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-66.9K
Shares Outstanding
7.73M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph N. Forkey | Chief Executive Officer, President, Treasurer & Director | 364.6K | — |
| Wayne Coll | CFO, Principal Accounting Officer & Secretary | 301.6K | male |
| Joseph Traut | Chief Operating Officer | 275.6K | male |
| Divaker Mangadu | President of Ross Optical Division | 180.0K | male |
| Clay Schwabe | Vice President of Sales & Marketing | — | male |
| Richard E. Forkey | Founder, Advisor to the Chief Executive Officer & Director Emeritus | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for POCI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
